Natco Pharma declares interim dividend of ₹1.25 per share
Natco Pharma (NATCOPHARM) said its board has declared a interim dividend of ₹1.25 per equity share. The company is valued at about ₹14,425 crore.
What happened
Natco Pharma (NATCOPHARM) told the exchanges on 13 November 2026 at 02:21 PM that its board has declared a interim dividend of ₹1.25 per equity share.
From the filing: "The Board of Directors of the Company at their meeting held today have Declared 2 nd interim dividend of Rs.1.25 ps. (One Rupee and twenty five paise only) ( 62.50 %) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2026-27."
How big is it?
At the latest price of ₹805.4, the ₹1.25 payout amounts to 0.16% of the share price.
Company snapshot
Natco Pharma is a small-cap company in the Healthcare sector, with a market value of about ₹14,425 crore.
The stock last traded at ₹805.4, against a 52-week range of ₹773.6–₹1,216.8 (33.8% below the high).
Before this filing the shares had moved +1.1% over the month and −10.9% over three months. Average daily turnover over the last 20 sessions was about ₹37.35 crore.
Promoters held 49.42% at the end of Q1 FY27. Foreign institutions owned 16.99% and domestic institutions 5.62%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 1,329 | 480.7 | 26.84 |
| Q2 FY26 | 1,363 | 518.4 | 28.94 |
| Q3 FY26 | 647 | 151.5 | 8.46 |
| Q4 FY26 | 739 | 267.9 | 14.96 |
| Q1 FY27 | 735 | 206.5 | 11.53 |
What history shows
BCEIE's records show 2 previous dividend filings from the company since May 2026.
Across 34 similar disclosures by other Healthcare companies, shares moved −0.6% on average the next day and −0.4% over five days; 44% of them rose the next day.
Market-wide, 1,091 dividend filings with an impact score of 50 or more saw an average next-day move of +0.1%, with 45% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- 13 November 2026: Board meeting — Financial Results/Dividend.
In the news
Recent coverage elsewhere (links open the original publisher):
- Khaitan & Co acts on NATCO Pharma ₹1,279 crore rights issue
- Natco Pharma Q2FY27 Results: Net profit falls 61% YoY to ₹203 crore
- Natco Pharma stock: Promoters acquire 2.21 million rights shares
- Natco Pharma declares interim dividend of ₹1.25 per share
- Natco Pharma stock awaits results and dividend decision Friday
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.